Biogen

Biogen Japan develops and supplies treatments in neuroscience, covering multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, amyotrophic lateral sclerosis and Parkinson's disease, and joins international clinical trials for most of its parent's pipeline. Its office is in Nihonbashi, Chuo-ku, Tokyo, and its parent in Cambridge, Massachusetts is Biogen Inc.